Total planned funding: $673,084,413
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $137,243,593 |
Nigeria | $103,910,857 |
Haiti | $99,381,569 |
Uganda | $77,297,058 |
Ethiopia | $44,756,433 |
Zambia | $39,854,293 |
Zimbabwe | $27,579,550 |
Côte d'Ivoire | $26,584,050 |
Rwanda | $19,343,384 |
Malawi | $14,371,612 |
Tanzania | $10,145,536 |
Dominican Republic | $9,349,631 |
Cameroon | $8,475,175 |
Mozambique | $8,341,702 |
Guyana | $7,014,789 |
Namibia | $6,615,543 |
Botswana | $6,142,839 |
Kenya | $5,319,457 |
Vietnam | $4,711,739 |
Central America Region | $4,124,520 |
Caribbean Region | $3,502,474 |
Angola | $1,930,000 |
Ukraine | $1,772,000 |
Lesotho | $1,312,478 |
Ghana | $1,167,700 |
Democratic Republic of the Congo | $1,050,000 |
Indonesia | $750,000 |
South Sudan | $470,000 |
Cambodia | $350,000 |
Eswatini | $196,431 |
China | $20,000 |
Asia Regional Program | $0 |
Central Asia Region | $0 |
Organizational Types
Implementing Agency | $673,084,413 |
Program Areas
Care | $181,228,719 |
Treatment | $177,747,391 |
Prevention | $154,238,292 |
Governance and Systems | $117,935,436 |
Testing | $41,834,575 |
Budget Codes
HTXS: Treatment: Adult Treatment | $140,659,244 |
HKID: Care: Orphans and Vulnerable Children | $79,996,112 |
HBHC: Care: Adult Care and Support | $62,241,762 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $54,781,536 |
HLAB: Laboratory Infrastructure | $43,672,050 |
HVOP: Sexual Prevention: Other Sexual Prevention | $42,476,713 |
HVCT: Testing: HIV Testing and Counseling | $41,834,575 |
OHSS: Health Systems Strengthening | $39,266,815 |
HVSI: Strategic Information | $34,996,571 |
HVTB: Care: TB/HIV | $26,674,103 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $23,802,009 |
PDTX: Treatment: Pediatric Treatment | $22,711,322 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,864,885 |
HMBL: Biomedical Prevention: Blood Safety | $14,745,289 |
HTXD: Treatment: ARV Drugs | $14,376,825 |
PDCS: Care: Pediatric Care and Support | $12,316,742 |
HMIN: Biomedical Prevention: Injection Safety | $1,417,860 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $150,000 |
Top Partner Programs
University of Maryland - Institute of Human Virology, Nigeria:
$52,006,707
View countries
All Countries
2010 | $52,006,707 |
John Snow, Inc:
$26,085,825
View countries